YU81101A - Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija - Google Patents

Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Info

Publication number
YU81101A
YU81101A YU81101A YUP81101A YU81101A YU 81101 A YU81101 A YU 81101A YU 81101 A YU81101 A YU 81101A YU P81101 A YUP81101 A YU P81101A YU 81101 A YU81101 A YU 81101A
Authority
YU
Yugoslavia
Prior art keywords
octan
polymorphs
pharmaceutical compositions
citrate
pharmaceutical composition
Prior art date
Application number
YU81101A
Other languages
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU81101A publication Critical patent/YU81101A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Abstract

Jedan kristalni polimorfni oblik citrata (monohidrat citrata) (2S,3S)-N-(metoksi-5-t-butil-fenil)metil-1-azobiciklo[2,2,2]oktan-3-amina i njegova farmaceutska kompozicija. Farmaceutska kompozicija polimorfnog oblika ukoliko monohidrat citrata ima dodatne prednosti u pogledu stabilnosti za formulaciju u lečenju povraćanja. Davanje ove farmaceutske kompozicije u obliku oralnih doza, prvenstveno u obliku tableta ili kapsula ili intravenski, dovodi do brze relaksacije.
YU81101A 1999-06-01 2000-05-18 Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija YU81101A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
YU81101A true YU81101A (sh) 2004-07-15

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
YU81101A YU81101A (sh) 1999-06-01 2000-05-18 Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Country Status (49)

Country Link
US (1) US6255320B1 (sh)
EP (1) EP1181290B1 (sh)
JP (1) JP3830816B2 (sh)
KR (1) KR100476606B1 (sh)
CN (1) CN1146565C (sh)
AP (1) AP2001002349A0 (sh)
AR (1) AR033331A1 (sh)
AT (1) ATE244239T1 (sh)
AU (1) AU767334B2 (sh)
BG (1) BG65240B1 (sh)
BR (1) BR0011094A (sh)
CA (1) CA2372238C (sh)
CO (1) CO5170463A1 (sh)
CY (1) CY2007011I2 (sh)
CZ (1) CZ295819B6 (sh)
DE (1) DE60003679T2 (sh)
DK (1) DK1181290T3 (sh)
DZ (1) DZ3050A1 (sh)
EA (1) EA003731B1 (sh)
EC (1) ECSP003508A (sh)
EE (1) EE200100656A (sh)
ES (1) ES2199825T3 (sh)
GT (1) GT200000087A (sh)
HK (1) HK1046284A1 (sh)
HN (1) HN2000000077A (sh)
HR (1) HRP20010904A2 (sh)
HU (1) HUP0201301A3 (sh)
IL (1) IL146406A0 (sh)
MA (1) MA26742A1 (sh)
MX (1) MXPA01012325A (sh)
MY (1) MY133508A (sh)
NO (1) NO20015848L (sh)
NZ (1) NZ515349A (sh)
OA (1) OA11956A (sh)
PA (1) PA8496101A1 (sh)
PE (1) PE20010209A1 (sh)
PL (1) PL196046B1 (sh)
PT (1) PT1181290E (sh)
SI (1) SI1181290T1 (sh)
SK (1) SK285820B6 (sh)
SV (1) SV2001000093A (sh)
TN (1) TNSN00120A1 (sh)
TR (1) TR200103473T2 (sh)
TW (1) TWI285204B (sh)
UA (1) UA66925C2 (sh)
UY (1) UY26176A1 (sh)
WO (1) WO2000073304A1 (sh)
YU (1) YU81101A (sh)
ZA (1) ZA200109775B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070155782A1 (en) * 2004-01-30 2007-07-05 Hickman Mary A Nk-1 receptor antagonists anesthesia recovery
PL1713504T3 (pl) * 2004-01-30 2017-12-29 Zoetis Services Lcc Przeciwdrobnoustrojowe środki konserwujące w celu uzyskania wielodawkowego preparatu stosując beta-cyklodekstryny dla ciekłych postaci dawkowania
BRPI0507301A (pt) * 2004-01-30 2007-06-26 Pfizer Prod Inc composições farmacêuticas de antagonistas do receptor de nuerocinina e ciclodextrina e métodos para melhor toleráncia no local de injeção
ATE380811T1 (de) * 2004-02-02 2007-12-15 Pfizer Prod Inc Verfahren zur herstellung von 1-(2s,3s)-2- benzhydril-n-(5-tert.-butyl-2- methoxybenzyl)chinuklidin-3-amin
TR201902687T4 (tr) * 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100214905B1 (ko) * 1991-05-31 1999-08-02 디. 제이. 우드, 스피겔 알렌 제이 퀴누클리딘 유도체
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PA8496101A1 (es) 2002-07-30
HK1046284A1 (en) 2003-01-03
TWI285204B (en) 2007-08-11
DK1181290T3 (da) 2003-09-29
MA26742A1 (fr) 2004-12-20
BR0011094A (pt) 2002-03-19
CN1146565C (zh) 2004-04-21
DZ3050A1 (fr) 2004-03-27
CN1353711A (zh) 2002-06-12
KR100476606B1 (ko) 2005-03-18
HUP0201301A3 (en) 2002-10-28
ATE244239T1 (de) 2003-07-15
PE20010209A1 (es) 2001-03-01
PT1181290E (pt) 2003-09-30
CA2372238A1 (en) 2000-12-07
OA11956A (en) 2006-04-13
SV2001000093A (es) 2001-11-08
AU4424800A (en) 2000-12-18
GT200000087A (es) 2001-11-22
IL146406A0 (en) 2002-07-25
MXPA01012325A (es) 2002-07-22
BG106204A (en) 2002-07-31
CA2372238C (en) 2006-12-19
CZ295819B6 (cs) 2005-11-16
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
EE200100656A (et) 2003-02-17
JP3830816B2 (ja) 2006-10-11
ES2199825T3 (es) 2004-03-01
WO2000073304A1 (en) 2000-12-07
UA66925C2 (uk) 2004-06-15
CO5170463A1 (es) 2002-06-27
PL196046B1 (pl) 2007-11-30
SK285820B6 (sk) 2007-09-06
HN2000000077A (es) 2001-02-02
UY26176A1 (es) 2000-12-29
TR200103473T2 (tr) 2002-04-22
DE60003679T2 (de) 2004-05-27
HUP0201301A2 (en) 2002-08-28
EA200101108A1 (ru) 2002-04-25
NZ515349A (en) 2004-03-26
SK17332001A3 (sk) 2002-07-02
AU767334B2 (en) 2003-11-06
TNSN00120A1 (fr) 2005-11-10
MY133508A (en) 2007-11-30
EP1181290B1 (en) 2003-07-02
KR20020010688A (ko) 2002-02-04
NO20015848D0 (no) 2001-11-30
DE60003679D1 (de) 2003-08-07
EA003731B1 (ru) 2003-08-28
PL352716A1 (en) 2003-09-08
BG65240B1 (bg) 2007-09-28
ZA200109775B (en) 2002-11-28
SI1181290T1 (en) 2003-12-31
HRP20010904A2 (en) 2003-02-28
CZ20014269A3 (cs) 2002-04-17
EP1181290A1 (en) 2002-02-27
CY2007011I1 (el) 2010-07-28
ECSP003508A (es) 2002-02-25
AP2001002349A0 (en) 2001-12-31
AR033331A1 (es) 2003-12-17
CY2007011I2 (el) 2010-07-28
JP2003501354A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
DK1126828T3 (da) Oral indgivelse af adenosin-analoger
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
AP2003002763A0 (en) Controlled release formulations for oral administration
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija
TW200517127A (en) Novel composition
AR024411A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo[2.2.2]oct-3-ilamina y sus composiciones farmaceuticas.
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
WO2002055062A3 (en) Pharmaceutical tablet comprising paroxetine mesylate
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
DE69800210D1 (de) Wasserfreies Mittel auf Lactulosebasis
MY145885A (en) Controlled release formulations for oral administration
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
TH57759A3 (th) ยาเม็ดที่มีการปลดปล่อยในทันที
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
KR950016757A (ko) 약물중독 치료제 조성물
IE34397L (en) Therapeutic composition containing benzodiazepine derivative